← All trials
NCT05128721
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 14, 2021
- Primary completion
- Feb 23, 2023
- Completion date
- May 23, 2023
- First posted
- Nov 22, 2021
- Last posted
- Nov 22, 2021
- Enrollment
- 72
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Research Center, EgyptLead sponsor
- Government of EgyptOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.